7817 — Paramount Bed Holdings Co Balance Sheet
0.000.00%
- ¥130bn
- ¥96bn
- ¥106bn
- 76
- 64
- 50
- 72
Annual balance sheet for Paramount Bed Holdings Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 42,462 | 48,362 | 54,069 | 53,232 | 46,746 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 25,839 | 27,343 | 28,574 | 30,572 | 36,823 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 76,848 | 86,144 | 94,035 | 97,135 | 95,496 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 38,810 | 39,804 | 41,751 | 43,579 | 45,670 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 144,257 | 154,358 | 164,281 | 172,293 | 180,020 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22,212 | 23,720 | 25,387 | 26,300 | 24,897 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 37,191 | 40,536 | 42,606 | 43,596 | 44,004 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 107,066 | 113,822 | 121,675 | 128,697 | 136,016 |
Total Liabilities & Shareholders' Equity | 144,257 | 154,358 | 164,281 | 172,293 | 180,020 |
Total Common Shares Outstanding |